GLOBUS MEDICAL INC (GMED)
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Address
2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403
Founded
2003
Number of Employees
5,000
Website
http://www.globusmedical.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | $105 | - | $144 | $226 | $85 | $140 |
| Average Price | - | - | - | - | - | - | $38.91 | - | $61.45 | $52.11 | $52.25 | $50.90 |
| # Shares Purchased | - | - | - | - | - | - | 2,691 | - | 2,351 | 4,329 | 1,627 | 2,750 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | 77.3% | - | 12.3% | 32.4% | 32.1% | 35.6% |
| S&P 500 Return to Date | - | - | - | - | - | - | 74.8% | - | 37.3% | 31.3% | 7.4% | 37.7% |
| Excess Total Return | - | - | - | - | - | - | 2.5% | - | -25.0% | 1.1% | 24.6% | -2.1% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | 66% | - | 58% | 73% | 90% | 64% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at GMED make a trade.
Creating a free account takes less than one minute